GAT Therapeutics is a clinical stage biopharma targeting orphan fibrotic diseases. We partner with leading researchers and clinicians to translate discoveries into patient outcomes. Our leading drug candidate GTX-11 has the potential to become mainstay therapy for orphan fibrotic diseases.
This company has no teams yet
This company has no offices yet